Say Hello!
Don’t be shy.

   

Maxwellia

Maxwellia

Home > Investment> Maxwellia

The world’s first prescription (Rx) to Over the Counter (OTC) switch incubator, Maxwellia’s novel approach converts prescription drugs into versions that can be purchased without prescription from pharmacies and supermarkets; a process known as ‘switching’. The funding round was partially completed via the BioCity angel investment platform and will support the development of three innovative products in the areas of women’s health and healthy lifestyle currently in the pipeline at different stages, two of which are undergoing the approval process with the Medicines and Healthcare products Regulatory Agency (MHRA).



X
X
X
X